BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14687068)

  • 1. Advances in treatment of mood and anxiety disorders: focus on atypical antipsychotics.
    Yatham LN; Kennedy SH; Lam RW
    Bipolar Disord; 2003; 5 Suppl 2():5-6. PubMed ID: 14687068
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotics and suicide in mood and anxiety disorders.
    Sharma V
    Bipolar Disord; 2003; 5 Suppl 2():48-52. PubMed ID: 14700012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders.
    Blier P
    J Psychiatry Neurosci; 2005 Jul; 30(4):304. PubMed ID: 16049572
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical antipsychotics for mood and anxiety disorders: safe and effective adjuncts?
    Blier P
    J Psychiatry Neurosci; 2005 Jul; 30(4):232-3. PubMed ID: 16049565
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction.
    Alamo C; López-Muñoz F
    Rev Psiquiatr Salud Ment; 2012; 5 Suppl 1():1-2. PubMed ID: 23265761
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological management of mood and anxiety disorders in headache patients.
    Griffith JL; Razavi M
    Headache; 2006 Oct; 46 Suppl 3():S133-41. PubMed ID: 17034391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for mood and anxiety disorders: quetiapine and aripiprazole.
    Sajatovic M
    Curr Psychiatry Rep; 2003 Aug; 5(4):320-6. PubMed ID: 12857536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Sleep therapy' or medical malpractice?
    Zabow T; Stein DJ; Hawkridge S
    S Afr Med J; 1997 Dec; 87(12):1707. PubMed ID: 9497844
    [No Abstract]   [Full Text] [Related]  

  • 9. Datapoints: prescription patterns for mood and anxiety disorders in a community sample.
    Mojtabai R
    Psychiatr Serv; 1999 Dec; 50(12):1557. PubMed ID: 10577871
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical setting.
    Coplan J; Gugger JJ; Tasleem H
    J Affect Disord; 2013 Sep; 150(3):868-71. PubMed ID: 23726783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety, Inflammatory Markers, and Antipsychotics.
    Wagner KD
    J Clin Psychiatry; 2017 Mar; 78(3):332-333. PubMed ID: 28394507
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of atypical antipsychotics in mood disorders.
    Yatham LN
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S9-14. PubMed ID: 12832944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
    Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole: striving towards euthymia with a novel mechanism of action.
    McIntyre RS
    J Affect Disord; 2011 Jan; 128 Suppl 1():S1-2. PubMed ID: 21220075
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of atypical antipsychotics in anxiety.
    Vulink NC; Figee M; Denys D
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):429-49. PubMed ID: 21345655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical uses of atypical antipsychotics.
    Brooke NS; Wiersgalla M; Salzman C
    Harv Rev Psychiatry; 2005; 13(6):317-39. PubMed ID: 16373327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of antipsychotic prescribing in a private psychiatric hospital.
    Botvinik L; Ng C; Schweitzer I
    Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional vs. atypical antipsychotic medications.
    Barbui C; Cipriani A; Tansella M
    N Engl J Med; 2006 Mar; 354(9):972-4; author reply 972-4. PubMed ID: 16514706
    [No Abstract]   [Full Text] [Related]  

  • 19. Mood and anxiety symptoms in an adolescent with Pervasive Developmental Disorder Not Otherwise Specified and moderate mental retardation.
    Williams DT; Hirsch S; Coffey B
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):721-6. PubMed ID: 17979592
    [No Abstract]   [Full Text] [Related]  

  • 20. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
    Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.